ALVGX | VIVIX | ALVGX / VIVIX | |
Total Expense Ratio | 0.64 | 0.04 | 1,600% |
Annual Report Gross Expense Ratio | 0.64 | 0.04 | 1,600% |
Fund Existence | 8 years | 27 years | - |
Gain YTD | 11.472 | 6.730 | 170% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.07B | 195B | 2% |
Annual Yield % from dividends | 1.85 | 2.19 | 85% |
Returns for 1 year | 6.95 | 9.75 | 71% |
Returns for 3 years | 21.89 | 34.32 | 64% |
Returns for 5 years | 26.32 | 74.87 | 35% |
Returns for 10 years | N/A | 116.26 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CTIGX | 15.35 | 0.19 | +1.25% |
Calamos Timpani SMID Growth I | |||
ADNAX | 20.47 | 0.24 | +1.19% |
American Beacon ARK Transfmt Innov A | |||
LADFX | 24.13 | 0.28 | +1.17% |
Lord Abbett Developing Growth F | |||
CMGSX | 38.30 | 0.34 | +0.90% |
BlackRock Mid-Cap Growth Equity Svc | |||
PGIOX | 35.77 | 0.12 | +0.34% |
Putnam Focused Equity R |